Diagnostic media

Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 2, 424 4, A61K 4900, C07C10126, C07F 938, G01N 2402

Patent

active

046474471

ABSTRACT:
A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more central ion or ions of an element with an atomic number of 21 to 29, 42, 44 or 57 to 83 and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.

REFERENCES:
patent: 4125599 (1978-11-01), Wiegert
patent: 4167564 (1979-09-01), Jensen
patent: 4206132 (1980-06-01), Sievers
patent: 4478816 (1984-10-01), Ledley et al.
Chem. Abstracts 91:133246k (1979).
Chemical Abstracts 87:1879b 1977, Chemical Abstracts 93:31813s, 1980, Chemical Abstracts 93:81186k, 1980, Chemical Abstracts 96:115204u, 1982, Chemical Abstracts 95:38681x, 1981.
Article 115 of EPC filing paper (12-4-84).
G. Levy et al, "Paramagnetic Relaxation Agents . . . ", Journal of the American Chemical Society, 96, 678-681 (1974).
P. C. Lauterbur et al, "Augmentation of Tissue Water Proton Spin-Lattice Relaxation Rates by In Vivo Addition of Paramagnetic Ions", Frontiers of Biological Energetics, vol. I, 752-759, (Encl. 2).
Bertinchamps, A. J., et al, "Interdependence of Routes Excreting Manganese", Am. J. Phsiol., 211 (i):217-224, 1966.
Cotzias, George C., "Manganese Versus Magnesium: Why are They So Similar In Vitro and So Different In Vivo?", Brookhaven National Laboratory, Upton, L. I., New York, pp. 98-103.
Davies, J. T., "The Clinical Significance of the Essential Biological Metals Codon 1572", Chapter IV--Manganese, pp. 69-80.
Doyle, F. H., et al., "Relaxation Rate Enhancement Observed In Vivo by NMR Imaging", Proceedings of NMR Imaging Symposium held in Nashville, Tenn., on Oct. 26-27, 1980, and abstracted on Journal of Computer Assisted Tomography 5 (2) 295-296.
Dwek, R. A., "Proton Relaxation Enhancement Probes", Advances in Molecular Relaxation Processes, 4(1972) 1-53, Elsevier Pub. Co., Amsterdam.
Eisinger, J., et al., "Transition Metal Binding in DNA Solutions", The Journal of Chemical Physics, vol. 36, No. 7, Apr. 1, 1962, pp. 1721-1729.
Forsberg, John H., "Sc, Y, La--Lu Rare Earth Elements--Part D 1", Gmelin Handbuch der Anorganischen Chemie, 8th ed., Springer-Verlag, New York, 1980, pp. 198-204.
Hosain, F., et al., "Ytterbium--169 Diethylenetriaminepentaacetic Acid Complex--A New Radiopharmaceutical for Brain Scanning", Radiology 91, 1199-1203, 1968.
Lauterbur, P. C., "Progress in NMR Zeugmatographic Imaging", Phil. Trans. R. Soc. Lond. B 289, 483-87 (1980).
Morgan, I. O., et al., "Proton Spin Relaxation in Aqueous Solutions of Paramagnetic Ions . . . ", The Journal of Chemical Physics, vol. 31, No. 2, Aug. 1959, pp. 365-368.
Pykett, Ian L., "Nuclear Magnetic Resonance, or NMR, Can Reveal the Distribution of Atoms in a Sample of Material. It Can Do the Same in the Body, Generating Images of Internal Structure without the Use of X Rays", NMR Imaging in Medicine, pp. 78-88.
Rote Liste 1977/78.
Weinmann, H. J., et al., "Characteristics of Gadoilnium-DTPA Complex. A Potential NMR Contrast Agent", in AJR 142, 619-624 (1984).
Brady et al, Radiology, 144, 343 (1982).
Young et al., J. Comput. Tomography 5,6:543-46 (1981).
Brash et al, AJR, 142:625-630, Mar. 1984.
Carr et al, The Lancet, Mar. 3, 1984, 484-486.
Mendonca-Dias et al, "Paramagnetic Contrast Agents in Nuclear Magnetic Resonance Medical Imaging", Seminars in Nuclear Medicine, vol. XIII, No. 4 (Oct., 1983) pp. 364-376.
Tyler et al, Ultrasonic Imaging 3, 323-329 (1981).
James J. Dechter & George C. Levy, "Aqueous Relaxation Reagents in Nitrogen--15 NMR", Journal of Magnetic Resonance 39, pp. 207-215 (1980).
Dennis R. Burton et al, Progress in NMR Spectroscopie, vol. 13, pp. 1-45: Proton Relaxation Enhancement (PRE) in Biochemistry: A Critical Survey.
Derwent Publications, Abstracts Nos.: 29038 D/16 (4-2-81); 61698V/35 (6-22-74); 07413X/04 (1-13-76); 78609B/43 (1-30-79); 8497X/46 (10-29-76); 81534B/45 (9-29-79); 23893B/12 (3-13-79); 02446 D/03 (1-7-81); 05092C/03 (1-1-80); 34726 D/20 (5-6-81);150/429 (1979); 221/170 (1977); 124/026 (1981); 135A/020 (1975); and 144/005 (1979).
"Probleme der Chelat-Therapie," A. Catsch, Naturwissenschaften (1968), pp. 473-477.
Elgavish et al, Journal of the American Chemical Society, 99:6, Mar. 16, 1977, pp. 1762-1765.
Ovitt et al, Improved Instrumentation Etc., NTIS No. PB82-118688, Sep. 1, 1979.
Ovitt et al, Improved Instrumentation Etc., NTIS No. PB 272 617, May, 1977.
Ovitt et al, Improved Instrumentation Etc., NTIS No. PB 268 277, Apr., 1976.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic media does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic media, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic media will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1015934

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.